ErleaDx

MISSION To develop high quality diagnostics products for early cancer detection. Our current focus is on lung cancer. We have a patented blood-based biomarker panel that enables the detection of lung cancer with high accuracy at an early stage. This allows medical staff to make rapid triage and treatment decisions when diagnosing a patient’s condition or monitoring a treatment response. We emphasize on Point-Of-Care (POC) diagnostics for lung cancer screening. We aim to bring convenience to people while delivering lab-quality results within minutes instead of hours. We are incorporating microfluidic and biosensors expertise into an innovative and integrated device. We believe in high quality products that can improve customer satisfaction and patient outcomes. Together, we can work towards saving more lives. We are actively seeking seed investment for our company. Please feel free to reach out to have a chat. cherry.chia@erleadx.com